These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 9691110

  • 21. Update on the management of Crohn's disease.
    Buchner AM, Blonski W, Lichtenstein GR.
    Curr Gastroenterol Rep; 2011 Oct; 13(5):465-74. PubMed ID: 21792543
    [Abstract] [Full Text] [Related]

  • 22. [New research results give hope. Causal therapy of Crohn disease in sight].
    MMW Fortschr Med; 2004 Apr 01; 146(14):42-3. PubMed ID: 15344754
    [No Abstract] [Full Text] [Related]

  • 23. [Anti-TNF therapy and Crohn's disease].
    Peyrin-Biroulet L.
    Gastroenterol Clin Biol; 2008 May 01; 32(5 Pt 1):478-81. PubMed ID: 18439777
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Oral Crohn disease. Apropos of a case].
    Lambert F, Reychler H.
    Rev Stomatol Chir Maxillofac; 1997 Dec 01; 98(5):299-302. PubMed ID: 9471674
    [Abstract] [Full Text] [Related]

  • 26. Effectiveness of controlled-release budesonide in preserving bone mineral density in patients with Crohn's disease.
    Abreu MT.
    Nat Clin Pract Gastroenterol Hepatol; 2005 May 01; 2(5):210-1. PubMed ID: 16265201
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
    MMW Fortschr Med; 2005 Apr 28; 147(17):58-9. PubMed ID: 15903063
    [No Abstract] [Full Text] [Related]

  • 30. [Acute episode].
    Schölmerich J, German Society for Digestive and Metabolic Diseases.
    Z Gastroenterol; 2003 Jan 28; 41(1):27-30. PubMed ID: 12541170
    [No Abstract] [Full Text] [Related]

  • 31. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
    González Carro P, Pérez Roldán F, Roncero García Escribano O, Lafuente R, Legaz Huidobro ML, Amigo Echenagusía A.
    J Clin Apher; 2006 Dec 28; 21(4):249-51. PubMed ID: 16607627
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Budesonide: its role in Crohn's disease therapy.
    Coleman CI, Reddy P, White CM.
    Conn Med; 2002 Sep 28; 66(9):523-6. PubMed ID: 12369546
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Budesonide: a useful tool in the maintenance treatment of Crohn's disease?
    Schoon EJ.
    Neth J Med; 2007 Oct 28; 65(9):316-7. PubMed ID: 17954949
    [No Abstract] [Full Text] [Related]

  • 39. [New therapeutic data in inflammatory colitis].
    Karsenti P.
    Ann Gastroenterol Hepatol (Paris); 1996 Oct 28; 32(1):10. PubMed ID: 8669802
    [No Abstract] [Full Text] [Related]

  • 40. The management of fistulizing oral Crohn's disease with infliximab.
    Staines KS, Green R, Felix DH.
    J Oral Pathol Med; 2007 Aug 28; 36(7):444-6. PubMed ID: 17617840
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.